Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $169.76 USD
Change Today 0.00 / 0.00%
Volume 0.0
UTHR On Other Exchanges
Symbol
Exchange
Frankfurt
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Richard Giltner

Director, Chairman of Audit Committee and Member of Nominating & Governance Committee, United Therapeutics Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 1 different organizations across 1 different industries.

See Board Relationships
50$502,517

Background*

Mr. Richard Giltner served as the Managing Director of Societe Generale Asset Management until October 15, 2008 and as Head of the European Office for its fund of hedge funds group since 2006. From 2003 to 2006, Mr. Giltner was the Global Head of Foreign Exchange options for the investment banking arm of Societe Generale. He has been a Director at United Therapeutics Corporation since April 2009. He has over twenty years of experience in the financial sector. His areas ...

Read Full Background

Corporate Headquarters*

1040 Spring Street
Silver Spring, Maryland 20910

United States

Phone: 301-608-9292
Fax: 301-608-9291

Board Members Memberships*

2009-Present
Director, Chairman of Audit Committee and Member of Nominating & Governance Committee

Education*

BA 1987
Northwestern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$87,917
Total Calculated Compensation$502,517
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UTHR:US $169.76 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jeffrey M. Leiden M.D., Ph.D.Chairman, Chief Executive Officer and President
Vertex Pharmaceuticals Incorporated
$1.1M
Jean-Paul Clozel M.D.Founder, Chief Executive Officer, Member of Management Board and Director
Actelion Ltd.
SFr.2.7M
David L. Hallal Chief Executive Officer and Director
Alexion Pharmaceuticals, Inc.
$696.1K
Mark C. Rohr Chairman of the Board, Chief Executive Officer and President
Celanese Corporation
$1.1M
Shigenobu Maekawa President and Representative Director
Nippon Shinyaku Co. Ltd.
--
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UNITED THERAPEUTICS CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.